EUVIMEDEUVIMED entdecken
Crossref

Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Disease: A Single‐Center Retrospective Study

Shu-Ping Han iD, Yi-Hsing Chen, Wen-Nan Huang iD, Yi-Ming Chen, Tsu-Yi Hsieh, Wei-Ting Hung, Ching-Tsai Lin, Chih-Wei Tseng, Kuo-Tung Tang iD, Yu-Wan Liao, Tsai-Hung Yen iD, Hsin-Hua Chen iD und 8 weitere

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Shu-Ping Han und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Connective Tissue Diseases, Echocardiography, Arterial Pressure. Die Arbeit nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to identify indicators for the early diagnosis and management of pulmonary arterial hypertension (PAH) in patients with connective tissue disease (CTD).

Method

This retrospective study included patients with CTD who met the criteria for right heart catheterization (RHC) according to contemporary guidelines for pulmonary hypertension (PH) with an intermediate to high echocardiographic probability of PH at a medical center in Taiwan. The data collected was analyzed.

Results

This study enrolled 92 patients, comprising 21 with systemic sclerosis (SSc) and 71 without SSc (non‐SSc). PH and PAH were diagnosed in 67 (72.8%) and 55 (59.8%) patients, respectively, and 41 (44.6%) patients required PAH‐specific medications. A high echocardiographic probability of PH significantly predicted both PH and PAH in all patients (adjusted odds ratio [OR] 7.30, 95% confidence interval [CI] 2.34–22.76 and OR 6.02, 95% CI 1.65–21.93), as well as in the non‐SSc subgroup (adjusted OR 20.51 [4.41–95.45] and 15.95 [2.62–96.92]). N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) ≥ 300 pg/mL predicted PH in the overall cohort and non‐SSc subgroup (adjusted OR 3.55 [1.15–10.96] and 5.22 [1.15–23.66]). Pericardial effusion was associated with PH and PAH in the overall cohort (adjusted OR 11.99 [1.35–106.62] and 11.13 [1.23–101.07]) but not in the non‐SSc subgroup. None of the aforementioned parameters significantly associated with the need for PAH‐specific medications.

Conclusions

A high echocardiographic probability of PH and NT‐proBNP ≥ 300 pg/mL predict PH in CTD patients. Pericardial effusion may further aid in PH/PAH detection, though not in the non‐SSc subgroup. RHC remains essential to confirm treatment eligibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionConnective Tissue DiseasesEchocardiographyArterial PressureHypertension, PulmonaryPulmonary ArteryHumansRetrospective StudiesFemaleMaleMiddle AgedEarly DiagnosisPredictive Value of TestsNatriuretic Peptide, BrainAdultBiomarkersPeptide FragmentsAgedTaiwanRisk FactorsCardiac Catheterization

Stichwörter der Autor:innen

NT‐proBNPconnective tissue diseaseechocardiographymultidisciplinarypulmonary arterial hypertensionpulmonary hypertensionright heart catheterization

Substanzen

Natriuretic Peptide, BrainBiomarkersPeptide Fragmentspro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Medical Education, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Children's Medical Center, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Center of Rheumatology and Immunology, China Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

ORCID-Profile: Shu-Ping Han, Wen-Nan Huang, Kuo-Tung Tang, Tsai-Hung Yen, Hsin-Hua Chen

Zitieren

APA

Han, S. P., Chen, Y. H., Huang, W. N., Chen, Y. M., Hsieh, T. Y., Hung, W. T., Lin, C. T., Tseng, C. W., Tang, K. T., Liao, Y. W., Yen, T. H., Chen, H. H., Lin, Y. P., Huang, C. Y., Lai, C. H., Lin, W. W., Liang, K. W., Hsu, C. Y., Fu, P. K., & Chen, Y. W. (2025). Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Disease: A Single‐Center Retrospective Study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70503

Vancouver

Han SP, Chen YH, Huang WN, Chen YM, Hsieh TY, Hung WT, et al. Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Disease: A Single‐Center Retrospective Study. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70503

BibTeX
@article{Han2025,
  author = {Han, Shu-Ping and Chen, Yi-Hsing and Huang, Wen-Nan and Chen, Yi-Ming and Hsieh, Tsu-Yi and Hung, Wei-Ting and Lin, Ching-Tsai and Tseng, Chih-Wei and Tang, Kuo-Tung and Liao, Yu-Wan and Yen, Tsai-Hung and Chen, Hsin-Hua and Lin, Yen-Po and Huang, Chi-Yao and Lai, Chih-Hung and Lin, Wei-Wen and Liang, Kae-Woei and Hsu, Chiann-Yi and Fu, Pin-Kuei and Chen, Yu-Wei},
  title = {Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Disease: A Single‐Center Retrospective Study},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70503}
}
Kostenlos starten →